• Ingredion’s 2Q 2026 earnings call drew CEO James Zallie, Interim CFO Jason Payant, IR VP Noah Weiss; analysts joined from Oppenheimer, Benchmark, Barclays, Stephens, BMO, UBS, Heather Jones Research.
• 2Q net sales rose 1% to USD 1.85 billion; adjusted operating income fell 5% to USD 258 million on Argo disruption, Mexico pressures.
• Texture and Healthful Solutions net sales rose 5% on 7% volume growth; tapioca root costs rose over 40% YTD, pricing lag 1-1.5 quarters.
• Argo exited June at normal production rates; management expects historical margins toward year-end as inventory costs clear.
• Guidance reaffirmed: 2026 adjusted EPS USD 10.3-10.9; Tate & Lyle deal targets USD 2.7 billion revenue, USD 130 million synergies by 2030.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ingredion Incorporated published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.